Nicole Kelsey - 18 Feb 2026 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Chief Legal Officer
Signature
/s/ Nicole Kelsey
Issuer symbol
RCEL
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 16:30:05 UTC
Previous filing
22 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KELSEY NICOLE Chief Legal Officer C/O AVITA MEDICAL, INC., 28159 AVENUE STANFORD, SUITE 200, VALENCIA /s/ Nicole Kelsey 19 Feb 2026 0001714653

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +98,390 98,390 18 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +145,060 $0.000000 145,060 18 Feb 2026 Common Stock 145,060 $4.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026.
F2 Includes unvested RSUs.
F3 These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026.